Jutta Reinhard-Rupp is the Head of the Global Health Institute at Merck, based in Switzerland. Her focus is the discovery and development of innovative healthcare solutions including drugs, diagnostics and devices for most vulnerable populations such as children and their mothers in developing countries. The disease focus of the institute is on Schistosomiasis, Malaria and emerging antimicrobial resistance. Jutta received her PhD at the Max-Planck Institute in Tübingen and after her postdoctoral training, she joined biopharmaceutical industry in various assignments. She also serves as scientific advisor at various boards, including CouNTDown in the UK and EDCTP, the European & Developing Countries Clinical Trials Partnership.